DOCSLIB.ORG

National Guidelines for Paediatric Hiv and Aids Treatment and Care

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
National Guidelines for Paediatric Hiv and Aids Treatment and Care NATIONAL GUIDELINES FOR PAEDIATRIC HIV AND AIDS TREATMENT AND CARE FEDERAL MINISTRY OF HEALTH NIGERIA 2007 COPY RIGHT PAGE ISBN Number…….. FEDERAL MINISTRY OF HEALTH NIGERIA 2007 1 LIST OF CONTRIBUTORS NAMES ORGANISATION/ADDRESS Prof. Kike Osinusi Department of Paediatrics, UCH, Ibadan Prof. W. N. Ogala Department of Paediatrics, ABUTH, Zaria Dr. Edna Iroha Department of Paediatrics, LUTH, Idi-Araba, Lagos Dr. A. I. Rabasa Department of Paediatrics, UMTH, Maiduguri Dr. A. Nte Department of Paediatrics, UPTH, Port Harcourt Dr. E. A. Adejuyigbe Department of paediatrics, OAUTH, Ile-Ife Dr. S. Oguche Department of Paediatrics, JUTH, Jos Dr. S. D. Pam Department Paediatrics, JUTH, Jos Dr. L.W. Umar Department of Paediatrics, ABUTH, Zaria Dr. Isaac Elon Department of Paediatrics, FMC, Gombe Dr. Kolade Ernest Department of Paediatrics, UITH, Ilorin Dr. O. Oniyangi Department of Paediatrics, National Hospital, Abuja Dr. Mariya Mukhtar-Yola Department of Paediatrics, AKTH, Kano Dr. O.A. Owolabi Department of Paediatrics, UITH, Ilorin Dr. J.U. Ojukwu Department of Paediatrics, EBSU, Abakaliki Dr. G. Eke Department of Paediatrics, UPTH, Port Harcourt Dr. Abieyuwa Emokpae Massey Street Children’s Hospital, Lagos Dr. Rosemary Audu NIMR, Lagos Dr. Georgina Odaibo Department of Virology, UCH, Ibadan Dr. Pat Matemilola NEPWHAN, Abuja Dr. Abiola Davies UNICEF, Abuja Dr. Tunde Adegboyega WHO, Abuja Dr. Pyande Mongi WHO, Abuja Dr. Niyi Ogundiran WHO, Abuja Dr. N. Sani-Gwarzo CDC, Abuja Dr. E. O. Jaiyesimi CDC, Abuja Dr. C. Omeogu USAID, Abuja Dr. O. Ibe USAID, Abuja 2 Dr. Sunny Ochigbo APIN PLUS/Harvard PEPFAR, Lagos Dr. J. Mafeni ENHANSE/CCM, Abuja Dr. Shafiq Essajee Clinton Foundation, Abuja Mr. Stephen Kisayke Clinton Foundation, Abuja Dr. L. Anomnachi Clinton Foundation, Abuja Prof. John Farley IHV-Nigeria, Abuja Dr. David Bowman IHV-Nigeria, Abuja Dr. M. J. Gambo IHV-Nigeria, Abuja Dr. Orode Doherty ICAP Nigeria, Abuja FMOH STAFF Dr. A. Akinsete HIV and AIDS Division Dr. O. Salawu HIV and AIDS Division Dr. Evelyn Ngige HIV and AIDS Division Dr. A. Lawanson HIV and AIDS Division Dr. A. Adedeji HIV and AIDS Division Dr. L Uzono HIV and AIDS Division Dr. D. Bako HIV and AIDS Division Dr. Emi Monye HIV and AIDS Division Dr. B. Ibrahim HIV and AIDS Division Mrs. O. F. Adegoke HIV and AIDS Division Mr. S. A.Egbewumi HIV and AIDS Division Mrs Ima Dada HIV and AIDS Division Mrs. O. A .J. Adebari HIV and AIDS Division Mr. O. A. Ombungadu HIV and AIDS Division Dr. Olurunfemi. Amoran HIV and AIDS Division 3 ACKNOWLEDGMENTS The Federal Ministry of Health appreciates the dedication and commitment of all those who contributed in various ways to the development and production of this document. The development of these guidelines was made possible with the support of our partners especially UNICEF and Clinton Foundation. Their continued support and technical assistance are highly appreciated. The contributions of all the former and current Directors of Public Health, National Coordinators and staff of the National AIDS/STIs Control Programme are highly appreciated. Dr Ngozi Njepuome Director Public Health Federal Ministry of Health 4 FOREWORD Twenty-six years after the first case of Acquired Immunodeficiency Syndrome (AIDS) was diagnosed, the Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome (HIV and AIDS) pandemic is now widely recognised as a major public health crisis which affects not only the lives of individuals, but also the future socio-economic development of nations. The HIV and AIDS pandemic disproportionately affect children and young adults. It is now an increasingly important cause of childhood morbidity and mortality in many African countries including Nigeria and has slowed down or reversed the gains of the child survival efforts of the last decade. This has become even more significant because children profoundly depend on adults, not only for physical and emotional needs, but also for the formulation and implementation of policies and programmes that affect their survival and development. In Nigeria it is estimated that one HIV-exposed child is born every five minutes. In recognition of the magnitude of the HIV and AIDS problem in Nigeria, the Federal Government has put in place a multi-sectoral response to prevent and control the epidemic. Part of this effort is the Health Sector Response being implemented by the Federal Ministry of Health. The development of these guidelines is part of the treatment, care and support strategies of the Health sector for the implementation of the Paediatric HIV and AIDS Initiative. The guidelines provide essential and relevant information needed by health workers not only to understand paediatric HIV and AIDS, but also to control and manage it. The Government expects that all those providing care for children with HIV and AIDS will strive to attain the standards prescribed in these guidelines. Professor Eyitayo Lambo Honourable Minister of Health 5 ABOUT THE GUIDELINES The Federal Ministry of Health with the assistance of UNICEF in 2003 developed the first draft of the National Guidelines for the Management of Paediatric HIV and AIDS, in response to increasing paediatric HIV and AIDS and the neglect of children in the National HIV programme. This is part of the multi-sectoral response of the Federal Government to the HIV pandemic. Although the final print of that document was not produced, it provided the template for the inclusion of paediatric HIV and AIDS management in the 2005 Guidelines for the Use of Antiretroviral (ARV) Drugs in Nigeria. However the 2005 Guidelines was considered inadequate in many aspects of paediatric HIV care. This realisation, in addition to the recent information on HIV and AIDS necessitated the current review of the document. The Guidelines provide current evidence-based scientific information on paediatric HIV and AIDS. It reviews the epidemiology, pathophysiology, clinical features, management and prevention of HIV and AIDS including associated conditions e.g. Tuberculosis (TB) co-infection. The legal and ethical issues related to HIV and AIDS are also briefly discussed. It is written for healthcare providers at all levels responsible for the care of children both in public and private sectors. It will provide information for the implementation of the Paediatric HIV and AIDS programme throughout the country. Since situations at different levels of care vary, users should adapt it to their settings. It will facilitate the scale up of treatment, care and support of children infected with HIV and AIDS. In the use of these Guidelines, health care providers at all levels must realize the need to establish linkages with pre-existing programmes to ensure efficient use of resources. Linkages with the following programmes will therefore need to be established (Fig. i.). • The Prevention of Mother-to-Child Transmission of HIV (PMTCT) • The Adult Antiretroviral Therapy (ART) • The HIV Counselling and Testing(HCT) • Home-Based care (HBC) for HIV-infected persons 6 • Orphans and Vulnerable Children (OVC) • Integrated Maternal, Newborn and Child Health • School Health COMMUNITY SUPPORT • ADULT ART INTEGRATED PROGRAMMES PROGRAMME MATERNAL, INCLUDING • HCT SERVICES NEWBORN AND HOME-BASED • TB AND OTHER CHILD HEALTH CARE SPECIALISED SERVICES CLINICS PAEDIATRIC PREVENTION OF ADOLESCENT HIV AND AIDS MOTHER-TO- AND YOUTH TREATMENT, CHILD HEALTH CARE AND TRANSMISSION SERVICES SUPPORT SERVICES PROGRAMME ORPHANS AND SCHOOL HEALTH VULNERABLE PAEDIATRIC OUT- CHILDREN’S PROGRAMME AND OTHERS PATIENT AND PROGRAMME IN-PATIENT SERVICES SERVICES Fig. i. Linkages between paediatric HIV and AIDS and other programmes 7 TABLE OF CONTENTS Page List of contributors ...................................................................................................................... I Acknowledgements ...................................................................................................................... III Foreword ...................................................................................................................... IV About the Guidelines ...................................................................................................................... V Table of contents ...................................................................................................................... VII List of figures ...................................................................................................................... IX List of tables ...................................................................................................................... X List of annexes ...................................................................................................................... XII Acronyms ...................................................................................................................... XIII Chapter 1: Introduction ...................................................................................................................... 1 Chapter 2: Virology ...................................................................................................................... 2.1 Classification and structure 22. Variability of HIV isolates 2.3 Cellular receptors 2.4 Replication 2.5 Natural history in children below 6 years 2.6 Natural history of HIV infection in children ≥ 6 years 2.7 Factors predicting prognosis Chapter 3: Diagnosis of HIV and AIDS ..................................................................
Load more

Recommended publications
  • INSTITUTO OSWALDO CRUZ Doutorado Em Biologia Celular E Molecular
    INSTITUTO OSWALDO CRUZ Doutorado em Biologia celular e Molecular CONTRIBUIÇÃO AO ESTUDO DA DIVERSIDADE DO HIV-1 NO BRASIL: CARACTERIZAÇÃO GENOTÍPICA E FENOTÍPICA DE AMOSTRAS DE HIV-1 OBTIDAS EM DIFERENTES REGIÕES GEOGRÁFICAS JOSÉ CARLOS COUTO FERNANDEZ Rio de Janeiro 2000 i PÓS-GRADUAÇÃO EM BIOLOGIA CELULAR E MOLECULAR INSTITUTO OSWALDO CRUZ CONTRIBUIÇÃO AO ESTUDO DA DIVERSIDADE DO HIV-1 NO BRASIL: CARACTERIZAÇÃO GENOTÍPICA E FENOTÍPICA DE AMOSTRAS DE HIV-1 OBTIDAS EM DIFERENTES REGIÕES GEOGRÁFICAS CONTRIBUTION TO THE STUDY OF HIV-1 DIVERSITY IN BRAZIL: GENOTYPICAL AND PHENOTYPICAL CHARACTERIZATION OF HIV-1 SAMPLES OBTAINED IN DIFFERENT GEOGRAPHICAL REGIONS Por JOSÉ CARLOS COUTO FERNANDEZ Tese submetida a pós-graduação em Biologia Celular e Molecular do Instituto Oswaldo Cruz como parte dos requisitos para obtenção do título de doutor em Biologia Celular e Molecular – área de concentração Biologia Molecular. Orientadores: Prof. Dr. Bernardo Galvão Castro Filho Prof. Dra. Mariza Gonçalves Morgado Rio de Janeiro 2000 ii INSTITUTO OSWALDO CRUZ Pós-Graduação em Biologia celular e Molecular JOSÉ CARLOS COUTO FERNANDEZ CONTRIBUIÇÃO AO ESTUDO DA DIVERSIDADE DO HIV-1 NO BRASIL: CARACTERIZAÇÃO GENOTÍPICA E FENOTÍPICA DE AMOSTRAS DE HIV-1 OBTIDAS EM DIFERENTES REGIÕES GEOGRÁFICAS Trabalho realizado no Laboratório Avançado em Saúde Pública-LASP, Centro de Pesquisas Gonçalo Moniz, Fundação Oswaldo Cruz, Bahia e Laboratório de AIDS e Imunologia Molecular, Departamento de Imunologia, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, sob a orientação dos Prof. Dr. Bernardo Galvão Castro Filho e Prof. Dra. Mariza Gonçalves Morgado. Aprovada em: 20 de Janeiro de 2000 EXAMINADORES Prof. Dra. Vera Bongertz – Presidente Prof. Dr. Amilcar Tanuri-UFRJ Prof.
    [Show full text]
  • ACT UP-Gruppen in New York, San Francisco Und Ber- Lin Wäre Dieses Projekt Nicht Möglich Gewesen
    SONDERBAND FEUER UNTERM ARSCH Die AIDS-Aktionsgruppen in Deutschland und den USA Andreas Salmen (Hg.) Deutsch? AIDS-Hilfe e>VP- H^Wr.U V'vwQE 1 ;' iiiiHMwiMmff AIDS-FORUM D.A.H. Sonderband ACT UP: FEUER UNTERM ARSCH Die AIDS-Aktionsgruppen in Deutschland und den USA Eine Dokumentation herausgegeben von Andreas Salmen im Auftrag der Deutschen AIDS-Hilfe e.V. Übersetzungen aus dem Amerikanischen von Axel Stelten Ich widme diesen Band meinem langjährigen Lebenspartner Michael Fischer. INHALT Ich danke vor allem Klaus-Dieter Beißwenger und Christine Höpfner vom Lek- torat/Printmedien der Deutschen AIDS-Hilfe für fast grenzenlose Geduld und Unterstützung bei der Erstellung dieses Bandes. Ich danke Axel Stelten und Bernd Vielhaber für die Mitarbeit. Michael Callen, Dan Turner t, Cindy Patton, Larry Kramer, Vito Russo +, David Leavitt, Mark Harrington, Peter Staley, Jess-E Musique/Virgin Music (Pubs) Ltd. und den Fotografen Johannes Aevermann, Jake Peters und Florian Wüst für freundliche Abdruckgenehmigungen. Ohne diese Menschen und die ACT UP-Gruppen in New York, San Francisco und Ber- lin wäre dieses Projekt nicht möglich gewesen. Schließlich gilt herzlicher Dank Jimmy Somerville der Deutschen AIDS-Hilfe, die dieses Buch ermöglicht hat. Read My Lips (Enough Is Enough) 5 Berlin im September 1991 Andreas Salmen Andreas Salmen Einleitung 7 Impressum Michael Callen / Dan Turner AIDS-FORUM D.A.H. Sonderband, 1991 Geschichte der Selbsthilfe-Bewegung von Menschen mit AIDS 9 © Deutsche AIDS-Hilfe e.V. Nestorstraße 8-9 Denver-Prinzipien 15 1000 Berlin
    [Show full text]
  • NO. 133 MM 2020 in the Supreme Court of Pennsylvania
    133 MM 2020 No. 133 MM 2020 In the Supreme Court of Pennsylvania __________ PENNSYLVANIA DEMOCRATIC PARTY, ET AL. Petitioners, v. KATHY BOOCKVAR, IN HER CAPACITY AS SECRETARY OF THE COMMONWEALTH OF PENNSYLVANIA, ET AL., Respondents. __________ BRIEF FOR COMMON CAUSE PENNSYLVANIA; LEAGUE OF WOMEN VOTERS OF PENNSYLVANIA; THE BLACK POLITICAL EMPOWERMENT PROJECT; MAKE THE ROAD PENNSYLVANIA, A PROJECT OF MAKE THE ROAD STATES; PATRICIA M. DEMARCO; DANIELLE GRAHAM-ROBINSON, AND KATHLEEN WISE AS AMICI CURIAE ReceivedFiled 9/8/2020 4:27:524:27:00 PM Supreme Court Middle District TABLE OF CONTENTS INTEREST OF THE AMICI CURIAE ..................................................................... 1 SUMMARY OF ARGUMENT ................................................................................. 3 ARGUMENT ............................................................................................................. 6 I. COVID-19 HEALTH AND MORTALITY RISKS HAVE CREATED A SIGNIFICANT PUBLIC INTEREST IN SAFE AND SECURE ALTERNATIVES TO IN-PERSON VOTING............................................... 7 A. Pennsylvania Voters Are Legitimately Concerned About the Health Risks of In-Person Voting During the COVID-19 Pandemic ............................................................................................... 7 B. Mail-In Ballots and Drop-Boxes Are Secure and Reliable ................. 11 C. The Disruption of Mail Service May Disenfranchise Voters ............. 17 II. THE PENNSYLVANIA ELECTION CODE AND PENNSYLVANIA CONSTITUTION PERMIT THE USE
    [Show full text]
  • Progress Report Global Progralllllle on AIDS
    - - 1992-1993 - Progress Report Global Progralllllle on AIDS \\"orld I leah h Urgan1:=~1lll 111 The World Health Organization is a specialized agency of the United Nations with primary responsibility for international health matters and public health. Through this organization, which was created in 1948, the health professions of some 180 countries exchange their knowledge and experience with the aim of making possible the attainment by all citizens of the world by the year 2000 of a level of health that will permit them to lead a socially and economically productive life. By means of direct technical cooperation with its Member States, and by stimulating such cooperation among them, WHO promotes the development of comprehensive health services, the prevention and control of diseases, the improvement of environmental conditions, the development of human re­ sources for health, the coordination and development of biomedical and health services research, and the planning and implementation of health programmes. These broad fields of endeavour encompass a wide variety of activities, such as developing systems of primary health care that reach the whole population of Member countries; promoting the health of mothers and children; combat­ ing malnutrition; controlling malaria and other communicable diseases includ­ ing tuberculosis and leprosy; coordinating the global strategy for the prevention and control of AIDS; having achieved the eradication of smallpox, promoting mass immunization against a number of other preventable diseases; improving
    [Show full text]
  • By ADAM PENN-NICHOLSON Submitted in Partial Fulfillment of The
    CHARACTERIZATION AND EVALUATION OF APPROACHES TO ELICIT BROADLY REACTIVE NEUTRALIZING ANTIBODIES AGAINST HIV-1 by ADAM PENN-NICHOLSON Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Dissertation Advisors: Dr. Michael W. Cho and Dr. Michael M. Lederman Department of Molecular Biology and Microbiology Program of Molecular Virology CASE WESTERN RESERVE UNIVERSITY May, 2008 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the dissertation of ___________ Adam Nicholson _________________________________________ Candidate for the Ph.D. degree *. (Signed)____ Eric Arts, Ph.D.__________________________________________ (Chair of the committee) __________ Michael W. Cho, PhD _____________________________________ __________ Michael M. Lederman, M.D ________________________________ __________ Neil S. Greenspan, M.D., Ph.D._____________________________ __________ Man-Sun Sy, Ph.D._______________________________________ (Date) ____Feb 22, 2008___________________ *We also certify that written approval has been obtained for any proprietary material contained therein. This work is dedicated in loving memory to my grandfather, Edward Garth Penn (1923-2004), who instilled within me a deep sense of curiosity and respect for the natural world, and who taught me above all else to pursue my dreams, never let go, and smile with each step and, to South African President Thabo Mbeki, whose unorthodox policy on AIDS in the hardest hit nation on the planet during a time of immense crisis, drove me to pursue my dreams even further TABLE OF CONTENTS List of Tables…………………………………………………………………………...…8 List of Figures………………………………………………………………………..……9 Acknowledgements………………………………………………………………………12 Abbreviations……………………………………………………………………….……14 Abstract…………………………………………………………………………………..16 CHAPTER 1: LITERATURE REVIEW / INTRODUCTION………………………..…….………18 1.A. HIV and AIDS – History, epidemiology, impact and disease……....…19 A.
    [Show full text]
  • Aids Vaccine Literacy Toolkit This Document Is Part Implemented of a Project by the International Initiative
    core content core Aids Vaccine Literacy Toolkit This document is part of a project implemented by the International AIDS Vaccine Initiative. The development of this manual has been funded in part with fi nancial assistance of the European Union for use in East Africa. The contents of these documents are the sole responsibility of IAVI and may under no circumstances be construed as refl ecting the position of the European Union. Acknowledgements The AIDS Vaccine Literacy Core Content represents the committed effort of many IAVI staff members and consultants. Stacey Hannah managed the development of the book from concept to completion, compiled the information and drafted much of the content. Special acknowledgement for extensive writing and review of the Core Content goes to Emily Bass, Julie Becker, and Pat Fast. IAVI’s in-country staff members Bonnie Bender, Subhadra Menon and Emmanuel Mugisha provided valuable input and perspective. Many staff provided review and input on specifi c chapters, including Abigail Bing, Kate Bourne, Karen Chandler, Jean-Louis Excler, Sam Kalibala, Chrispin Kambili, Sushma Kapoor, Nzeera Ketter, Camille Massey, Megan McBride, Simon Noble, Vladimir Popovic, Claudia Schmidt, Chutima Suraratdecha, and Holly Wong. Michael Hariton contributed profi ciency and time to the graphic design, layout, and production of the Core Content. For inspiration of the “vaccine literacy” and toolkit concepts, and initial support in developing the Core Content, utmost appreciation goes to Mitchell Warren. First printing. To request copies of this book or other AIDS © Copyright International AIDS Vaccine Literacy materials, please contact: Vaccine Initiative, Inc. 2005 International AIDS Vaccine Initiative 110 William Street, 27th fl oor All information in this document may be New York, NY 10038 reproduced or copied without permission, Tel: +1.212.847.1111 provided the International AIDS Vaccine Fax: +1.212.847.1112 Initiative, Inc.
    [Show full text]
  • Corecontent Core
    p s content core International AIDS Vaccine Initiative 110 William Street, 27th floor New York, NY 10038 Tel: +1.212.847.1111 Fax: +1.212.8 NY 10038 Tel: 27th floor New York, Street, Initiative 110 William International AIDS Vaccine core AIDS Vaccine Literacy Toolkit 47.1112 Email: [email protected] Web: http://www.iavi.org http://www.iavi.org Web: 47.1112 Email: [email protected] Back cover Front cover Back cover Front cover without AIDS Imagine a world Inside front cover Inside back cover core content core AIDS Vaccine Literacy Toolkit Acknowledgements The AIDS Vaccine Literacy Core Content represents the committed effort of many IAVI staff members, consultants and partners. Stacey Hannah managed the development of the book from concept to completion, compiled the information and drafted much of the content. Special acknowledgement for extensive review of the Core Content 2nd edition goes to Julie Becker and Fran Priddy. Additional review was provided by Pat Fast, Tom Harmon, Alex Menezes, Shilpa Vuthoori and Holly Wong. Special thanks goes to Luz Barbosa and Marilyn Piels for leading the process of production and publication of the second edition with proficiency. IAVI extends appreciation to Grundini, Ltd. for its brilliant design of the Core Content and all other VAXLit Toolkit components. For inspiration of the “vaccine literacy” and toolkit concepts, utmost appreciation goes to Mitchell Warren. First printing 2005. The text of the AIDS Vaccine Literacy Core Second edition 2009. Content may be found online at © 2009 International AIDS Vaccine Initiative. www.iavi.org/vaxlit. All rights reserved. The International AIDS Vaccine Initiative, IAVI and the IAVI logo are To request copies of this book or other AIDS trademarks of the International AIDS Vaccine Vaccine Literacy materials, please contact: Initiative, Inc.
    [Show full text]
  • Spanish Glossary Feb24-2003.P65
    . o t n e i m a t a r t y s o ic n lí c s o y a s n e , n Un servicio del Departamento de Salud y ó ci Servicios Humanos de los Estados Unidos a ig st ve in AIDSinfo.nih.gov re ob l s ra de fe o rn bie go el or a p bad pro da a aliza actu más ación inform Ofrece la Glosario del VIH/SIDA Cuarta edición . o t n e i m a t a r t y s o ic n lí c s o y a s n e , n Un servicio del Departamento de Salud y ó ci Servicios Humanos de los Estados Unidos a ig st ve in AIDSinfo.nih.gov re ob l s ra de fe o rn bie go el or a p bad pro Marzo de 2003 da a aliza actu más ación inform Ofrece la Glosario del VIH/SIDA Cuarta edición Introducción AIDSinfo presenta la cuarta edición del Glosario de Terminología del VIH/SIDA. AIDSinfo incluye los servicios que se ofrecían a través del Servicio de Información de los Ensayos Clínicos sobre el SIDA (ACTIS) y del Servicio de Información sobre el Tratamiento del VIH/SIDA (ATIS). El glosario ha sido actualizado para incluir nuevos términos, últimas novedades sobre la terminología ya existente, y una lista de agencias federales con las que se puede comunicar para obtener más información. AIDSinfo es un proyecto del Departamento de Salud y Servicios Humanos de los Estados Unidos, patrocinado por una colaboración entre los Institutos Nacionales de la Salud, los Centros de Servicios de Medicare y Medicaid, la Administración de Recursos y Servicios de Salud, y los Centros de Prevención y Control de Enfermedades.
    [Show full text]
  • National Guidelines for Hiv and Aids Treatment and Care in Adolescents and Adults
    NATIONAL GUIDELINES FOR HIV AND AIDS TREATMENT AND CARE IN ADOLESCENTS AND ADULTS FEDERAL MINISTRY OF HEALTH ABUJA – NIGERIA MAY 2007 2 Foreword Since the first case of AIDS was reported in Nigeria twenty-one years ago, the Federal Government has in a myriad of ways activated machinery to combat the HIV virus. HIV/AIDS is a major public health problem which has taken its toll on the country, affecting not only the lives of individual men, women and children, but also the future socio-economic development of the nation. As part of its response, the Nigerian Government in 2002, initiated the National Anti-retroviral Access programme, providing ARVs at minimal cost to 10,000 persons. The country was the first in Africa to do this. Since then, and in collaboration with International partners, the number of people accessing ARVs has risen to over 100,000. The Guideline for the use of ARVs in Nigeria has been revised to ensure it provides essential, relevant and up-to-date information needed by health workers, not only to understand the course of HIV/AIDS in adults and adolescents, but also to control and manage it. The Government expects that all those providing care for People Living with HIV or AIDS in Nigeria will strive to attain the standard prescribed in this guideline. Prof. Eyitayo Lambo Honourable Minister of Health 3 Acknowledgement The Federal Ministry of Health appreciates the dedication and commitment of the Editorial team, the National ARV Committee and all Organisations who contributed to the revision this document. We commend all the individuals and organisations, national and International (WHO, CDC, USAID, APIN, GHAIN, IHVN, AIDSRelief, ICAP, JSI/DELIVER, ENHANSE, DFID, MSF, World Bank & Global Fund) who have committed themselves to ensuring that Anti-retroviral therapy is not only made available to as many as require it, but also in a manner that meets national and international standards.
    [Show full text]
  • Glossary of HIV/AIDS- Related Terms
    Glossary of HIV/AIDS- Related Terms 4th Edition September 2002 Glossary of HIV/AIDS- Related Terms 4th Edition Introduction The HIV/AIDS Treatment Information Service (ATIS) presents the fourth edition of the Glossary of HIV/AIDS-Related Terms. The glossary has been updated to include new terms, updates to existing terms, and a matrix of federal resources that can be contacted for additional information. ATIS is a Department of Health and Human Services project collaboratively sponsored by the National Institutes of Health, Centers for Medicare and Medicaid Services, Health Resources and Services Administration, and the Centers for Disease Control and Prevention. These agencies were instrumental in reviewing all of the terms presented in this edition. ATIS is your central resource for all federally approved HIV/AIDS treatment guidelines. With frequent updates to these guidelines being released through ATIS, it is essential for care providers and persons living with HIV/AIDS to know how to access the service: Toll-Free Number: 1–800–448–0440 (Hours of operation: Monday-Friday, 12:00 p.m. to 5:00 p.m.) Spanish available TTY/TTD: 1–888–480–3739 Fax Number: 1–301–519–6616 E-mail: [email protected] Internet Address: http://www.hivatis.org Trained bilingual information specialists can provide free, confidential, and personalized answers to your questions on HIV treatment options. Following is a list of other federal resources that can be contacted for additional information about HIV/AIDS. i Toll-Free: 800–448–0440 Fax: 301–519–6616 TTY: 888–480–3739 HIV/AIDS Spanish: Yes Treatment E-mail: [email protected] Information Service Web: www.hivatis.org (ATIS) Hours: Monday–Friday 12 p.m.
    [Show full text]